Skip to Main Content

Author Details

Amy J Mathers
University of Virginia Health System. Charlottesville
2006
95
33
Sarah J Ratcliffe (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
33593836Consecutive antibiotic shortages highlight discrepancies between microbiology and prescribing practices for intra-abdominal infections.Antimicrob Agents Chemother2023
37125227Successful Treatment of Persistent <i>Stenotrophomonas maltophilia</i> Bacteremia With Cefiderocol in an Infant.Open Forum Infect Dis2023
36946754Potential of Inaccurate Cefiderocol Susceptibility Results: a CLSI AST Subcommittee Advisory.J Clin Microbiol2023
36978246Reply to Davis et al.Clin Infect Dis2023
37463564Infectious Diseases Society of America 2023 Guidance on the Treatment of Antimicrobial Resistant Gram-Negative Infections.Clin Infect Dis2023
36625154Deconstructing the 2023 Clinical and Laboratory Standards Institute Revised Piperacillin-Tazobactam Breakpoints Against Pseudomonas aeruginosa.Clin Infect Dis2023
36719243Evaluation of Piperacillin-Tazobactam Testing against <i>Enterobacterales</i> by the Phoenix, MicroScan, and Vitek2 Tests Using Updated Clinical and Laboratory Standards Institute Breakpoints.J Clin Microbiol2023
36877020Fosfomycin Disk Diffusion Testing among Klebsiella pneumoniae Results in Frequent Inner Colonies and Categorical Disagreement Based on Conflicting Breakpoint Organization Recommendations.Microbiol Spectr2023
36001445Breaking Down the Breakpoints: Rationale for the 2022 Clinical and Laboratory Standards Institute Revised Piperacillin-Tazobactam Breakpoints Against Enterobacterales.Clin Infect Dis2023
35167966Tracking Klebsiella pneumoniae carbapenemase gene as an indicator of antimicrobial resistance dissemination from a hospital to surface water via a municipal wastewater treatment plant.Water Res2022
37552737Building-Level Wastewater Surveillance for SARS-CoV-2 in Occupied University Dormitories as an Outbreak Forecasting Tool: One Year Case Study.ACS ES T Water2022
35443782Disk Correlates for Revised Clinical and Laboratory Standards Institute <i>Enterobacterales</i> Piperacillin-Tazobactam MIC Breakpoints.J Clin Microbiol2022
35439291Infectious Diseases Society of America 2022 Guidance on the Treatment of Extended-Spectrum β-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with Difficult-to-Treat Resistance (DTR-P. aeruginosa).Clin Infect Dis2022
35529051Clinical challenges treating <i>Stenotrophomonas maltophilia</i> infections: an update.JAC Antimicrob Resist2022
36408469Reducing Repeat Blood Cultures in Febrile Neutropenia: A Single-Center Experience.Open Forum Infect Dis2022
36454695Outbreak of Burkholderia stabilis Infections Associated with Contaminated Nonsterile, Multiuse Ultrasound Gel - 10 States, May-September 2021.MMWR Morb Mortal Wkly Rep2022
35959207Safety and Efficacy of Dupilumab for the Treatment of Hospitalized Patients With Moderate to Severe Coronavirus Disease 2019: A Phase 2a Trial.Open Forum Infect Dis2022
34888640Setting Antimicrobial Susceptibility Testing Breakpoints: A Primer for Pediatric Infectious Diseases Specialists on the Clinical and Laboratory Standards Institute Approach.J Pediatric Infect Dis Soc2022
35007138A Novel Plasmid Entry Exclusion System in pKPC_UVA01, a Promiscuous Conjugative Plasmid Carrying the <i>bla</i><sub>KPC</sub> Carbapenemase Gene.Antimicrob Agents Chemother2022
35171828The effects of avoiding extended antimicrobial drain prophylaxis on Clostridioides difficile and postprocedural infection rates: a 5-year retrospective.J Neurosurg2022
35196802Convalescent Plasma for Preventing Critical Illness in COVID-19: a Phase 2 Trial and Immune Profile.Microbiol Spectr2022
34864936Infectious Diseases Society of America Guidance on the Treatment of AmpC β-Lactamase-Producing Enterobacterales, Carbapenem-Resistant Acinetobacter baumannii, and Stenotrophomonas maltophilia Infections.Clin Infect Dis2022
32645717The Practical Challenges of Making Clinical Use of the Quantitative Value for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Viral Load Across Several Dynamics.Clin Infect Dis2021
33830222Infectious Diseases Society of America Guidance on the Treatment of Extended-Spectrum β-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with Difficult-to-Treat Resistance (DTR-P. aeruginosa).Clin Infect Dis2021
33619508Convalescent plasma for preventing critical illness in COVID-19: A phase 2 trial and immune profile.medRxiv2021
33858836Development of Wastewater Pooled Surveillance of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) from Congregate Living Settings.Appl Environ Microbiol2021
33580233Implementation of a Rapid Phenotypic Susceptibility Platform for Gram-Negative Bloodstream Infections With Paired Antimicrobial Stewardship Intervention: Is the Juice Worth the Squeeze?Clin Infect Dis2021
33688686IL-13 is a driver of COVID-19 severity.medRxiv2021
33659895Navigating treatment approaches for presumed ESBL-producing infections.JAC Antimicrob Resist2021
34223109CON: Testing for ESBL production is unnecessary for ceftriaxone-resistant Enterobacterales.JAC Antimicrob Resist2021
34185704IL-13 is a driver of COVID-19 severity.JCI Insight2021
34259555Multidimensional Clinical Surveillance of Pseudomonas aeruginosa Reveals Complex Relationships between Isolate Source, Morphology, and Antimicrobial Resistance.mSphere2021
33106864Infectious Diseases Society of America Guidance on the Treatment of Extended-Spectrum β-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with Difficult-to-Treat Resistance (DTR-P. aeruginosa).Clin Infect Dis2021
33234179Colonization of carbapenem-resistant <i>Klebsiella pneumoniae</i> in a sink-drain model biofilm system.Infect Control Hosp Epidemiol2021
32224328Nutrients influence the dynamics of Klebsiella pneumoniae carbapenemase producing enterobacterales in transplanted hospital sinks.Water Res2020
31931046Risk factors for Klebsiella pneumoniae carbapenemase (KPC) gene acquisition and clinical outcomes across multiple bacterial species.J Hosp Infect2020
31960024Genomic dynamics of species and mobile genetic elements in a prolonged blaIMP-4-associated carbapenemase outbreak in an Australian hospital.J Antimicrob Chemother2020
32008698Collaborative Antimicrobial Stewardship for Surgeons.Infect Dis Clin North Am2020
33330878IgG Antibodies against SARS-CoV-2 Correlate with Days from Symptom Onset, Viral Load and IL-10.medRxiv2020
32917755Risk Factors Associated with Carbapenemase-Producing <i>Enterobacterales</i> (CPE) Positivity in the Hospital Wastewater Environment.Appl Environ Microbiol2020
32553019Genomic surveillance of <i>Escherichia coli</i> and <i>Klebsiella</i> spp. in hospital sink drains and patients.Microb Genom2020
32205351Reconciling the Potentially Irreconcilable? Genotypic and Phenotypic Amoxicillin-Clavulanate Resistance in <i>Escherichia coli</i>.Antimicrob Agents Chemother2020
30367005Droplet- Rather than Aerosol-Mediated Dispersion Is the Primary Mechanism of Bacterial Transmission from Contaminated Hand-Washing Sink Traps.Appl Environ Microbiol2019
31345843Managing All the Genotypic Knowledge: Approach to a Septic Patient Colonized by Different <i>Enterobacteriales</i> with Unique Carbapenemases.Antimicrob Agents Chemother2019
31340992The Role of <i>fosA</i> in Challenges with Fosfomycin Susceptibility Testing of Multispecies Klebsiella pneumoniae Carbapenemase-Producing Clinical Isolates.J Clin Microbiol2019
31041357Clinical Yield of a Molecular Diagnostic Panel for Enteric Pathogens in Adult Outpatients With Diarrhea and Validation of Guidelines-Based Criteria for Testing.Open Forum Infect Dis2019
31084655Use of a cohorting-unit and systematic surveillance cultures to control a Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae outbreak.Infect Control Hosp Epidemiol2019
30910889<i>Klebsiella quasipneumoniae</i> Provides a Window into Carbapenemase Gene Transfer, Plasmid Rearrangements, and Patient Interactions with the Hospital Environment.Antimicrob Agents Chemother2019
30965019<i>Mycobacterium avium</i> Complex Diversity within Lung Disease, as Revealed by Whole-Genome Sequencing.Am J Respir Crit Care Med2019
30928702Don't overlook the little guy: An evaluation of the frequency of small plasmids co-conjugating with larger carbapenemase gene containing plasmids.Plasmid2019
  • 1 - 50 of 95

Recommended Authors

University of Sao Paulo
Career Start Year 2014
Number of shared co-authors 0
Center for Access & Delivery Research and Evaluation (CADRE)
Career Start Year 2013
Number of shared co-authors 0
Department of Pharmacy, Beth Israel Deaconess Medical Center
Career Start Year 2013
Number of shared co-authors 0
Vanderbilt University Medical Center
Career Start Year 2012
Number of shared co-authors 0
Washington University School of Medicine
Career Start Year 2012
Number of shared co-authors 0
Massachusetts General Hospital
Career Start Year 2011
Number of shared co-authors 1
School of Public Health, University of Sao Paulo
Career Start Year 2008
Number of shared co-authors 0
Centers for Disease Control and Prevention
Career Start Year 2006
Number of shared co-authors 1
University "Magna Graecia"
Career Start Year 2006
Number of shared co-authors 0
University of Melbourne
Career Start Year 2006
Number of shared co-authors 0
University of Pittsburgh School of Medicine
Career Start Year 2006
Number of shared co-authors 0
Trinity Health St Joseph Mercy Hospital
Career Start Year 2005
Number of shared co-authors 0
Johns Hopkins University School of Medicine, The Johns Hopkins Hospital
Career Start Year 2004
Number of shared co-authors 0
Emory University School of Medicine
Career Start Year 2004
Number of shared co-authors 1
Center for Cancer Research, National Cancer Institute
Career Start Year 2003
Number of shared co-authors 0
Yale University School of Medicine
Career Start Year 2002
Number of shared co-authors 0
Harvard T H Chan School of Public Health, Harvard University
Career Start Year 2002
Number of shared co-authors 0
Children's Healthcare of Atlanta and Emory University School of Medicine
Career Start Year 2001
Number of shared co-authors 1
Rush University Medical Center
Career Start Year 2001
Number of shared co-authors 0
Wayne State University
Career Start Year 2000
Number of shared co-authors 2
National Centre for Infectious Diseases
Career Start Year 1998
Number of shared co-authors 0
University of Birmingham
Career Start Year 1998
Number of shared co-authors 0
International Health Management Associates Inc.
Career Start Year 1998
Number of shared co-authors 0
Institute of Biomedical Sciences, University of Sao Paulo, School of Pharmacy
Career Start Year 1998
Number of shared co-authors 0
William S. Middleton Memorial Veterans' Hospital
Career Start Year 1995
Number of shared co-authors 0
Hospital Universitario de Mostoles C/Dr. Luis Montes
Career Start Year 1995
Number of shared co-authors 1
Perelman School of Medicine, University of Pennsylvania
Career Start Year 1994
Number of shared co-authors 0
Hospital del Mar-IMIM, Universitat Pompeu Fabra, Instituto de Salud Carlos III
Career Start Year 1993
Number of shared co-authors 0
University of Nebraska Medical Center
Career Start Year 1993
Number of shared co-authors 1
Cleveland Clinic Lerner College of Medicine, Case Western Reserve University
Career Start Year 1986
Number of shared co-authors 1

Collaborators

University of Virginiagrid.412587.dgrid.27755.32 School of Medicine
Co-authored papers 12
Icahn School of Medicine at Mount Sinai
Co-authored papers 8
University of Virginia
Co-authored papers 6
University of Virginia
Co-authored papers 5
University of Virginia
Co-authored papers 4
University of Virginia
Co-authored papers 3
University of Virginia School of Medicine
Co-authored papers 3
Children's Hospital of Richmond at Virginia Commonwealth University
Co-authored papers 2
University of Virginia
Co-authored papers 2
Charite-Universitatsmedizin Berlin
Co-authored papers 2
University of Virginia
Co-authored papers 2
Lydia Becker Institute for Immunology & Infection, University of Manchester
Co-authored papers 2
Institute for Physiology, Charite-University Medicine Berlin
Co-authored papers 2
University of Virginia
Co-authored papers 2
Virginia Commonwealth University.
Co-authored papers 2
University of Virginia
Co-authored papers 2
Lydia Becker Institute for Immunology & Infection, University of Manchester
Co-authored papers 2
University of Virginia School of Medicine
Co-authored papers 2
Virginia Commonwealth University.
Co-authored papers 2
University of Virginia School of Medicine
Co-authored papers 2
Integrated Translational Health Research Institute of Virginia (iTHRIV)
Co-authored papers 2
University of Washington
Co-authored papers 2
Co-authored papers 2
University of Virginia
Co-authored papers 2
University of Virginia School of Medicine
Co-authored papers 2
Children's Hospital Los Angeles
Co-authored papers 1
Co-authored papers 1
Northwestern University Feinberg School of Medicine
Co-authored papers 1
University of Virginia School of Medicine
Co-authored papers 1
University of Virginia
Co-authored papers 1